Biology Agriculture Aquaculture Horticulture Postharvest Forestry Geography Environment Health

Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients

submitted by crazmeis 2 years and 1 month ago
Lower responsiveness to erythropoiesis-stimulating agents (ESA-R) predicts cardiovascular (CV) events. Whether ESA-R also affects the risk of end-stage renal disease (ESRD) is unknown. We evaluated ESA-R in 194 consecutive chronic kidney disease (CKD) patients, regularly seen in outpatient nephrology clinics, who started erythropoiesis-stimulating agent (ESA) therapy between 22–6. Exclusion criteria were causes of anaemia other than CKD or recent transfusion. ESA-R was calculated as (Hb1 – Hb)/time/ESA dose (g/dL/month/1 μg/week of ESA). Patients were classified, from lower to higher tertile of ESA-R, as poor, intermediate and good responders. Time to ESRD was the primary outcome. Age was 64 ± 16 years, 48% were male, 34% had diabetes and 32% had CV disease, glomerular filtration rate (GFR) 24 ± 13 mL/min/1.73 m2 and proteinuria .6 g/dL (interquartile range .2–1.9). First ESA dose was 23.7 ± 1.8 μg/week; haemoglobin (Hb) increased from 9.9 ± .8 g/dL to 1± 1.2 g/dL at first control, obtained after 1.4 ± .4 months. These changes corresponded to an ESA-R of .37 ± .38 g/dL/month/1 μg/week of ESA and tertiles limits were .17 and .47. Poor responders were younger and had lower GFR and higher proteinuria than intermediate and good responders. During the first 6 months of ESA therapy, poor responders showed lower Hb levels and sustained longer periods of Hb level <11 g/dL. During follow-up (median 3. years), 99 patients reached ESRD. At multivariable Cox's analysis, poor responsiveness was associated with higher risk of ESRD (hazard ratio 2.49, 95% confidence interval 1.28–4.84). ESA-R predicts renal prognosis in CKD patients followed in nephrology practice, where ESRD is the predominant outcome and ESA is commonly used at low dose.

Topic: Health

Add your comment

Please Login or Signup to leave a comment

Related stories

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
submitted by sodighepaar 1 year and 5 months ago - Topic: Health
Some hemodialysis patients require large doses of erythropoiesis-stimulating agents (ESAs) to manage anemia. These patients, termed "ESA hyporesponsive," have been characterized using various definitions. We applied three definitions of hyporesponsiveness to a large, national cohort of hemodialysis patients to assess the impact of definition on counts and on characteristics associated with hypo...

Pretransplantation Erythropoiesis-Stimulating Agent Hyporesponsiveness Is Associated with Increased Kidney Allograft Failure and Mortality
submitted by jadeth 8 months ago - Topic: Health
Poor response to erythropoiesis-stimulating agents (ESA) is associated with morbidity and mortality among dialysis patients. It is unclear whether the risk associated with poor ESA response during dialysis extends beyond kidney transplantation. We examined pretransplantation ESA response and its effect on allograft failure and mortality. MethodsThe cohort included all adult Medicare recipients ...

Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation
submitted by glinn234 1 year and 4 months ago - Topic: Health
Resistance to erythropoiesis-stimulating agents (ESAs) has been observed in a considerable proportion of patients with chronic kidney disease (CKD) and it is reportedly associated with adverse outcomes, such as increased cardiovascular morbidity, faster progression to end-stage renal disease (ESRD) and all-cause mortality. The major causes of ESA resistance include chronic inflammation producin...

Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?
submitted by harndag 1 year and 9 months ago - Topic: Health
The results of recent randomized, controlled trials in patients with chronic kidney disease and anemia have suggested that hyporesponsiveness to erythropoiesis stimulating agents (ESA) is a significant predictor of poor patient outcomes. Functional iron deficiency (FID) is the most common cause of suboptimal ESA response, and intravenous iron administration (IVFe) efficiently raises hemoglobin ...

The Relationship between Red Cell Distribution Width with Erythropoietin Resistance in Iron Replete Hemodialysis Patients
submitted by wosin 1 year and 7 months ago - Topic: Health
Recently, erythropoietin resistance (ER) has been shown to be related with cardiovascular and overall mortality in hemodialysis (HD) patients. Red blood cell distribution width (RDW) has also shown to be associated with cardiovascular and all cause mortality in general population. Thus in the current study we tested the hypothesis that RDW and erythropoietin resistance as determined by erythrop...

Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study
submitted by vonisomorebil 6 hours ago - Topic: Health
Previous epidemiological evidence has suggested that responsiveness to erythropoiesis-stimulating agents (ESAs) is related to prognosis in hemodialysis (HD) patients. We investigated the effects of hyporesponsiveness to ESA on mortality and cardiovascular events in Japanese HD patients, taking modifying factors into account. A total of 2,905 Japanese HD patients aged ≥18 years who received E...

Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients
submitted by dorodero 6 months ago - Topic: Health
Anemia is a common complication among hemodialysis (HD) patients. Although intravenous iron and erythropoiesis-stimulating agents revolutionized anemia treatment, about 10% of HD patients show suboptimal response to these agents. Systemic inflammation and increased serum hepcidin level may contribute to this hyporesponsiveness. Considering the anti-inflammatory properties of omega-3 fatty acids...

Anemia of Chronic Disease
submitted by welsani 11 months ago - Topic: Health
(ACD) or inflammation may be secondary to infections, autoimmune disorders, chronic renal failure, or malignancies. It is characterized by an immune activation with an increase in inflammatory cytokines and resultant increase in hepcidin levels. In addition, inappropriate erythropoietin levels or hyporesponsiveness to erythropoietin and reduced red blood cell survival contribute to the anemia. ...

Erythropoietin-Induced Erythroid Precursor Pool Depletion Causes Erythropoietin Hyporesponsiveness
submitted by lode 1 year and 4 months ago - Topic: Health
The purpose of this study is to demonstrate that the erythroid precursor depletion in bone marrow induced by recombinant human erythropoietin (rHuEPO) treatment may be another contributing factor to erythropoietin hyporesponsiveness. Healthy Wistar rats were given single dose (SD) or multiple doses (MD) of rHuEPO (100 IU/kg). In MD study, animals were challenged with thrice-weekly over two week...

Infections in chronic kidney disease
submitted by oenat 1 year and 10 months ago - Topic: Health
Infectious and cardiovascular (CV) complicationstake a huge toll on Chronic Kidney Disease and End Stage Renal Disease patients in terms of morbidity and mortality. Infection leads to increased mortality, directly as a result of infectious disease processes and indirectly as a risk factor for cardiovascular disease. Chronic activation with hyporesponsiveness may be the most accurate description...